New Jersey § 24:6m-2

§ 24:6m-2.

As used in sections 1 through 7 of this act: 1 “ Administration supplies ” means any supply associated with the administration of prescription drugs, including,

but not limited to, diabetes test strips, nebulizers, syringes, and needles. “ Anti-rejection drug ” means an over-the-counter drug or prescription drug that suppresses the immune system

to prevent or reverse the rejection of a transplanted organ. “ Board ” means the State Board of Pharmacy. “ Cancer drug ” means a prescription drug that is used to treat cancer or the side effects of cancer,

or that is used to treat the side effects of any other prescription drug that is used

to treat cancer or the side effects of cancer. “ Commissioner ” means the Commissioner of Health. “ Compounded drug ” means a sterile or nonsterile compounded formulation for dispensing or administration

pursuant to a prescription, that is prepared for a patient with needs that cannot

be met by a commercially available prescription drug. “ Controlled dangerous substance ” means the same as that term is defined by N.J.S.2C:35-2 . “ Correctional facility ” means a county or state correctional facility, county juvenile detention facility,

secure juvenile facility, federal prison, or other comparable facility. “ Donated drug ” means an over-the-counter drug or prescription drug that has been donated to a redistributor

in accordance with the provisions of this act. “ Donor ” means a drug manufacturer, wholesaler, repackager, returns processor, third-party

logistics provider, health care facility, correctional facility, pharmacy, or any

other person or entity that is properly licensed and authorized to possess prescription

drugs, and which elects to donate over-the-counter drugs, prescription drugs, or administration

supplies pursuant to this act. “ Drug donation program ” means a program, established pursuant to the provisions of this act, which accepts

the donation of unused over-the-counter drugs, prescription drugs, and administration

supplies that would otherwise be destroyed, and which provides for the redistribution

of those unused drugs and administration supplies to persons who are most in need. “ Grooming and hygiene product ” is soap or cleaning solution, shampoo, toothpaste, mouthwash, anti-perspirant, or

sun tan lotion or screen, regardless of whether the item meets the definition of “ over-the-counter drug .” “ Health care facility ” means a physician's office; a hospital; an outpatient clinic; a federally qualified

health center; a federally qualified health center look-alike; a rural health clinic;

a clinic that provides services under the federal Ryan White HIV/AIDS Program; a

mental health center or clinic; a Veterans Affairs hospital; and any other health

care facility licensed pursuant to P.L.1971, c. 136 ( C.26:2H-1 et seq. ), or a comparable facility licensed to operate within another state. “ Indigent ” means a person who has an income that is below 250 percent of the federal poverty

level. “ Out-of-State redistributor ” means a health care facility, pharmacy, wholesaler, returns processor, or other

person or entity that is properly licensed to operate in a state other than New Jersey,

and is authorized to dispense over-the-counter drugs and prescription drugs, and which

agrees to accept, repackage, transfer to other redistributors, and, if otherwise authorized

by law, dispense donated drugs and administration supplies to eligible individuals

pursuant to a prescription drug donation program established under the laws of the

state in which the person or entity is located. “ Over-the-counter-drug ” means a drug that contains a label that meets the requirements of 21 CFR 201.66 , including (1) a “Drug Facts” panel; or (2) a statement of the “active ingredient”

or “active ingredients” with a list of those ingredients contained in the compound,

substance, or preparation. “Over-the-counter drug” does not include a grooming and hygiene product. “ Prescriber ” means a licensed physician, physician assistant, or advanced practice nurse, or

any other person who is authorized by the appropriate State professional and occupational

licensing board to prescribe drugs and devices as provided by law. “ Prescription drug ” means any drug, intended for use in humans, which is required by federal or State

law or regulation to be dispensed only pursuant to a prescription. “ Prescription drug ” includes cancer drugs and anti-rejection drugs, but does not include any controlled

dangerous substance or compounded drug. “ Redistributor ” means a health care facility, pharmacy, wholesaler, returns processor, or any other

person or entity that is properly licensed and authorized to dispense over-the-counter

drugs and prescription drugs, and which agrees to accept, repackage, transfer to other

redistributors, and, if otherwise authorized by law, dispense donated drugs and administration

supplies to eligible individuals pursuant to this act. “ Redistributor ” includes an out-of-State redistributor. “ Returns processor ” shall mean the same as that term is defined by 21 U.S.C. s.360eee (18) . “ Returns processor ” includes a reverse distributor. “ Tamper-evident packaging ” means a package or container that has an immediate, outer, or secondary seal that

must be broken in order to gain access to the container's contents. “ Tamper-evident packaging ” includes partially used single-unit dose or blister pack and bottles or vials sealed

in pouches or with tamper-evident tape. “ Third-party intermediary ” means an organization that is not a wholesaler or third-party logistics provider,

and that facilitates the donation or transfer of over-the-counter drugs, prescription

drugs, and administration supplies for a drug donation program established pursuant

to this act, but which does not take possession or ownership of the drugs. “ Transaction date ” means the date at which ownership of the drug was donated or transferred between

two participants of the program as established by contract or other arrangement. If no such contract or arrangement exists, the transaction date shall be the date

the drug was accepted into inventory by the redistributor. 1

N.J.S.A. §§ 24:6M-1 to 24:6M-7.